These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 39340750)
41. Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D. Ratcliffe J; Flynn T; Terlich F; Stevens K; Brazier J; Sawyer M Pharmacoeconomics; 2012 Aug; 30(8):713-27. PubMed ID: 22788261 [TBL] [Abstract][Full Text] [Related]
42. EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec. Poder TG; Wang L; Carrier N BMJ Open; 2020 Sep; 10(9):e035722. PubMed ID: 32933957 [TBL] [Abstract][Full Text] [Related]
43. Valuation of the SF-6D Health States Is Feasible, Acceptable, Reliable, and Valid in a Chinese Population. Lam CL; Brazier J; McGhee SM Value Health; 2008; 11(2):295-303. PubMed ID: 18380642 [TBL] [Abstract][Full Text] [Related]
44. Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China. Xie S; Li M; Wang D; Hong T; Guo W; Wu J Health Qual Life Outcomes; 2023 Oct; 21(1):118. PubMed ID: 37904216 [TBL] [Abstract][Full Text] [Related]
45. A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best-Worst Scaling for Eliciting Preferences in Healthcare. Whitty JA; Oliveira Gonçalves AS Patient; 2018 Jun; 11(3):301-317. PubMed ID: 29177797 [TBL] [Abstract][Full Text] [Related]
46. Discrete choice experiments or best-worst scaling? A qualitative study to determine the suitability of preference elicitation tasks in research with children and young people. Rogers HJ; Marshman Z; Rodd H; Rowen D J Patient Rep Outcomes; 2021 Mar; 5(1):26. PubMed ID: 33689059 [TBL] [Abstract][Full Text] [Related]
47. Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Rashidi AA; Anis AH; Marra CA Health Qual Life Outcomes; 2006 Apr; 4():25. PubMed ID: 16626489 [TBL] [Abstract][Full Text] [Related]
48. A think aloud study comparing the validity and acceptability of discrete choice and best worst scaling methods. Whitty JA; Walker R; Golenko X; Ratcliffe J PLoS One; 2014; 9(4):e90635. PubMed ID: 24759637 [TBL] [Abstract][Full Text] [Related]
49. Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China. Guo W; Xie S; Wang D; Wu J Qual Life Res; 2024 Mar; 33(3):817-829. PubMed ID: 38167749 [TBL] [Abstract][Full Text] [Related]
50. A Comparison of the SF-6Dv2 and SF-6D UK Utility Values in a Mixed Patient and Healthy Population. McDool E; Mukuria C; Brazier J Pharmacoeconomics; 2021 Aug; 39(8):929-940. PubMed ID: 34043147 [TBL] [Abstract][Full Text] [Related]
51. An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders' Risk Tolerance for Hip Replacement Surgery. van Dijk JD; Groothuis-Oudshoorn CG; Marshall DA; IJzerman MJ Value Health; 2016 Jun; 19(4):316-22. PubMed ID: 27325322 [TBL] [Abstract][Full Text] [Related]
52. Preference Elicitation Techniques Used in Valuing Children's Health-Related Quality-of-Life: A Systematic Review. Bailey C; Howell M; Raghunandan R; Salisbury A; Chen G; Coast J; Craig JC; Devlin NJ; Huynh E; Lancsar E; Mulhern BJ; Norman R; Petrou S; Ratcliffe J; Street DJ; Howard K; Viney R; Pharmacoeconomics; 2022 Jul; 40(7):663-698. PubMed ID: 35619044 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the Measurement Properties of EQ-5D-5L and SF-6Dv2 in COVID-19 Patients in China. Ding N; Zhou H; Chen C; Chen H; Shi Y Appl Health Econ Health Policy; 2024 Jul; 22(4):555-568. PubMed ID: 38641755 [TBL] [Abstract][Full Text] [Related]
54. Psychometric performance of EQ-5D-5L and SF-6DV2 in measuring health status of populations in Chinese university staff and students. Zhou HJ; Zhang A; Wei J; Wu J; Luo N; Wang P BMC Public Health; 2023 Nov; 23(1):2314. PubMed ID: 37993793 [TBL] [Abstract][Full Text] [Related]
55. Estimation of a valuation function for a diabetes mellitus-specific preference-based measure of health: the Diabetes Utility Index. Sundaram M; Smith MJ; Revicki DA; Miller LA; Madhavan S; Hobbs G Pharmacoeconomics; 2010; 28(3):201-16. PubMed ID: 20151725 [TBL] [Abstract][Full Text] [Related]
56. Is Best-Worst Scaling Suitable for Health State Valuation? A Comparison with Discrete Choice Experiments. Krucien N; Watson V; Ryan M Health Econ; 2017 Dec; 26(12):e1-e16. PubMed ID: 27917560 [TBL] [Abstract][Full Text] [Related]
57. Psychometric performance of EQ-5D-5L and SF-6Dv2 in patients with lymphoma in China. Zhang A; Li J; Mao Z; Wang Z; Wu J; Luo N; Liu P; Wang P Eur J Health Econ; 2024 Dec; 25(9):1471-1484. PubMed ID: 38451345 [TBL] [Abstract][Full Text] [Related]
58. German tariffs for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluations at the end of life. Dams J; Huynh E; Riedel-Heller S; Löbner M; Brettschneider C; König HH Eur J Health Econ; 2021 Apr; 22(3):365-380. PubMed ID: 33475868 [TBL] [Abstract][Full Text] [Related]
59. Derivation of a UK preference-based value set for the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) to allow estimation of Mental Well-being Adjusted Life Years (MWALYs). Yiu HHE; Buckell J; Petrou S; Stewart-Brown S; Madan J Soc Sci Med; 2023 Jun; 327():115928. PubMed ID: 37201343 [TBL] [Abstract][Full Text] [Related]